Literature DB >> 16169127

Pyrrolo[3,4-c]quinoline-1,3-diones as potent caspase-3 inhibitors. Synthesis and SAR of 2-substituted 4-methyl-8-(morpholine-4-sulfonyl)-pyrrolo[3,4-c]quinoline-1,3-diones.

Dmitri V Kravchenko1, Volodymyr M Kysil, Sergey E Tkachenko, Sergey Maliarchouk, Ilya M Okun, Alexandre V Ivachtchenko.   

Abstract

Synthesis, biological evaluation and structure-activity relationships for a series of 2-substituted 4-methyl-8-(morpholine-4-sulfonyl)-1,3-dioxo-2,3-dihydro-1H-pyrrolo[3,4-c]quinolines are described. These compounds represent a new chemotype of nonpeptide small molecule inhibitors of caspase-3. Among the studied compounds, several potent inhibitors with IC50 in the range of 3-10 nM have been identified. The most active compound within this series, 7{49} and 7{58}, inhibited caspase-3 with IC50=3 nM.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16169127     DOI: 10.1016/j.ejmech.2005.07.011

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  12 in total

Review 1.  Small Molecule Active Site Directed Tools for Studying Human Caspases.

Authors:  Marcin Poreba; Aleksandra Szalek; Paulina Kasperkiewicz; Wioletta Rut; Guy S Salvesen; Marcin Drag
Journal:  Chem Rev       Date:  2015-11-09       Impact factor: 60.622

2.  6-Phenyl-5a,6,6a,7,12,13a-hexa-hydro-5H-benzo[6,7]indolizino[3,2-a]pyrrolizine.

Authors:  B Gunasekaran; S Kathiravan; R Raghunathan; V Renuga; V Manivannan
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-06-06

3.  Diethyl 1-acetyl-4'-(4-chloro-phen-yl)-5'-(4-nitro-phen-yl)-2-oxospiro-[indoline-3,3'-pyrrolidine]-2',2'-dicarboxyl-ate.

Authors:  Long He
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-09-09

4.  Diethyl 4-acetyl-5-(2-nitro-phen-yl)pyrrolidine-2,2-dicarboxyl-ate.

Authors:  Long He
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-11-17

5.  Methyl 3-[ferrocen-yl(hydr-oxy)meth-yl]-1-methyl-2'-oxospiro-[pyrrolidine-2,3'-indoline]-3-carboxyl-ate.

Authors:  E Theboral Sugi Kamala; S Nirmala; L Sudha; S Kathiravan; R Raghunathan
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-04-18

6.  (3RS,4SR)-Methyl 4-(2-chloro-5,8-di-methoxy-quinolin-3-yl)-1-phenyl-pyrrolidine-3-carboxyl-ate.

Authors:  Saida Benzerka; Abdelmalek Bouraiou; Sofiane Bouacida; Salah Rhouati; Ali Belfaitah
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-10-09

7.  3-Ethyl 2-methyl 8-bromo-2-phenyl-1,2,3,3a,4,9b-hexa-hydro-chromeno[4,3-b]pyrrole-2,3-dicarboxyl-ate.

Authors:  Long He
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-11-06

8.  Diethyl 4-meth-oxyoxalyl-3,5-diphenyl-pyrrolidine-2,2-dicarboxyl-ate.

Authors:  Yan-Qin He; Jin-Quan Chen
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-04-06

9.  (3aR,8bR)-3a,8b-Dihy-droxy-2-methyl-sulfanyl-3-nitro-1-phenyl-1,8b-di-hydro-indeno[1,2-b]pyrrol-4(3aH)-one.

Authors:  R A Nagalakshmi; J Suresh; V Jeyachandran; R Ranjith Kumar; P L Nilantha Lakshman
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-11-13

10.  Pharmacophore modeling and docking studies on some nonpeptide-based caspase-3 inhibitors.

Authors:  Simant Sharma; Arijit Basu; R K Agrawal
Journal:  Biomed Res Int       Date:  2013-09-08       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.